$500 million to be Spent Lobbying Congress on Healthcare Reform

In 2009, drug companies, medical device firms, insurance companies and other players in the medical industry will spend a record $500 million to influence the congressional vote on healthcare reform.


Before the passage of healthcare reform tackling the issue of pharmaceutical companies’ sky-high profits, the drug industry has been raising prices.


Four House leaders (Charles B. Rangel, D-N.Y.; Henry A. Waxman, D-Calif.; Pete Stark, D-Calif.; John Lewis, D-Ga.) and one senator (Bill Nelson D-Fla.) have called for two separate investigations into drug-company pricing.

“They are trying to influence the people who have the power,” states Josh Israel of the Center for Public Integrity. Now is the time to make your voice heard by Congress. Your voice is priceless when raised to elected officials debating key issues, including healthcare freedom of choice.